NANCY J LINDO-DRUSCH

Allopathic & Osteopathic Physicians|Family Medicine APPLETON, WI NPI 1821081035

General Payments — all program years on this page

$1,105.92

  • Category: General Payments
  • Program years: PY2018–2019
  • Record count: 74
  • As of (CMS publication): 2026-01-23

Latest program year (PY2019): $333.20 across 20 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2019) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $333.2020

By paying entity

Latest program year (PY2019) · sorted by reported total.

By program year

Program yearAmountRecords
2018 $772.7254
2019 $333.2020

Records — PY2019 (20)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
651349403 E.R. Squibb & Sons, L.L.C. $13.86 01/10/2019 Food and Beverage Undisputed 01/23/2026 View at CMS
651349431 E.R. Squibb & Sons, L.L.C. $12.40 05/23/2019 Food and Beverage Undisputed 01/23/2026 View at CMS
658038279 Lilly USA, LLC $12.88 02/18/2019 Food and Beverage Undisputed 01/23/2026 View at CMS
658058779 Lilly USA, LLC $14.40 05/16/2019 Food and Beverage Undisputed 01/23/2026 View at CMS
658058781 Lilly USA, LLC $13.49 07/29/2019 Food and Beverage Undisputed 01/23/2026 View at CMS
659669133 Novartis Pharmaceuticals Corporation $10.82 04/22/2019 Food and Beverage Undisputed 01/23/2026 View at CMS
670248569 GlaxoSmithKline, LLC. $14.61 03/29/2019 Food and Beverage Undisputed 01/23/2026 View at CMS
670730953 Allergan Inc. $14.33 09/30/2019 Food and Beverage Undisputed 01/23/2026 View at CMS
673819103 PFIZER INC. $12.65 06/03/2019 Food and Beverage Undisputed 01/23/2026 View at CMS
685069321 AstraZeneca Pharmaceuticals LP $14.11 02/07/2019 Food and Beverage Undisputed 01/23/2026 View at CMS
685112275 AstraZeneca Pharmaceuticals LP $12.15 07/22/2019 Food and Beverage Undisputed 01/23/2026 View at CMS
685434565 AstraZeneca Pharmaceuticals LP $12.78 05/30/2019 Food and Beverage Undisputed 01/23/2026 View at CMS
685472579 AstraZeneca Pharmaceuticals LP $11.85 04/29/2019 Food and Beverage Undisputed 01/23/2026 View at CMS
685593089 AstraZeneca Pharmaceuticals LP $14.23 08/05/2019 Food and Beverage Undisputed 01/23/2026 View at CMS
685668673 AstraZeneca Pharmaceuticals LP $11.26 03/11/2019 Food and Beverage Undisputed 01/23/2026 View at CMS
685962247 AstraZeneca Pharmaceuticals LP $12.50 06/20/2019 Food and Beverage Undisputed 01/23/2026 View at CMS
686015625 AstraZeneca Pharmaceuticals LP $83.34 07/30/2019 Food and Beverage Undisputed 01/23/2026 View at CMS
700077049 Boehringer Ingelheim Pharmaceuticals, Inc. $12.56 04/15/2019 Food and Beverage Undisputed 01/23/2026 View at CMS
700077051 Boehringer Ingelheim Pharmaceuticals, Inc. $16.95 01/14/2019 Food and Beverage Undisputed 01/23/2026 View at CMS
709219987 Ironwood Pharmaceuticals, Inc $12.03 05/09/2019 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2019_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.